Related Experiment Video
Updated: Jun 24, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Targeting Diabetes with Azole-derived Medicinal Agents
1Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara (Punjab) 144411, India.
Azole compounds show significant potential as antidiabetic agents, offering a promising alternative for managing type-2 diabetes. Their unique chemical structure facilitates interactions with biological targets, enhancing therapeutic efficacy.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Background:
- Azoles are versatile heterocyclic compounds with broad applications in medicine and materials science.
- Nitrogen-containing heterocycles are prevalent in FDA-approved drugs, highlighting their therapeutic importance.
- Azoles possess diverse pharmacological activities, including antimicrobial, antiviral, and antidiabetic properties.
Purpose of the Study:
- To review recent advancements in the development of azole-derived antidiabetic agents.
- To explore the potential of azoles as alternatives for type-2 diabetes management.
Main Methods:
- Literature review of recent research on azole-derived antidiabetic agents.
- Analysis of the chemical properties and biological interactions of azoles relevant to diabetes.
Main Results:
- Azoles demonstrate potent antidiabetic activity through specific interactions with physiological receptors and enzymes.
- The electron-rich nature of the azole moiety contributes to its therapeutic efficacy.
Conclusions:
- Azole-based compounds represent a promising class of therapeutic agents for type-2 diabetes.
- Further research into azole derivatives could lead to novel and effective diabetes treatments.
More Related Videos
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
07:30Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Dipeptidyl Peptidase 4 Inhibitors
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...